Topics

Asia Deal Watch: Qpex Partners Its Experimental Antibiotics With Brii In Greater China

14:29 EDT 25 Oct 2019 | SCRIP

Qpex licenses rights to its antibiotic portfolio in China to Brii Biosciences. Moberg and DongKoo partner on commercialization of onychomycosis...

      

Related Stories

 

Original Article: Asia Deal Watch: Qpex Partners Its Experimental Antibiotics With Brii In Greater China

NEXT ARTICLE

More From BioPortfolio on "Asia Deal Watch: Qpex Partners Its Experimental Antibiotics With Brii In Greater China"

Quick Search

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...